Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.16B |
| 2 |
Bank of America
BAC
|
+$855M |
| 3 |
Comcast
CMCSA
|
+$620M |
| 4 |
Amazon
AMZN
|
+$505M |
| 5 |
Micron Technology
MU
|
+$486M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$441M |
| 2 |
Palo Alto Networks
PANW
|
+$300M |
| 3 |
Verizon
VZ
|
+$286M |
| 4 |
Fidelity National Information Services
FIS
|
+$285M |
| 5 |
Stanley Black & Decker
SWK
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.08% |
| 2 | Financials | 6.03% |
| 3 | Industrials | 5.01% |
| 4 | Consumer Discretionary | 4.73% |
| 5 | Healthcare | 4.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BPMC
4001
DELISTED
Blueprint Medicines
BPMC
| $1.38M | ﹤0.01% |
+18,258
| New | +$1.28M |
|
|
WFT
4002
CALL
DELISTED
Weatherford International plc
WFT
| $1.38M | ﹤0.01% |
330,200
-32,100
| -9% | -$118K |
|
|
ZOES
4003
DELISTED
Zoe's Kitchen, Inc.
ZOES
| $1.38M | ﹤0.01% |
82,281
-191,225
| -70% | -$2.68M |
|
|
KEM
4004
PUT
DELISTED
KEMET Corporation
KEM
| $1.38M | ﹤0.01% |
91,300
+44,600
| +96% | +$849K |
|
4005
CALL
ProShares UltraShort Euro
EUO
$33.2M
| $1.37M | ﹤0.01% |
64,800
-5,700
| -8% | -$125K |
|
4006
Ford
F
$55.7B
| $1.37M | ﹤0.01% |
109,991
-550,925
| -83% | -$6.78M |
|
4007
Columbus McKinnon
CMCO
$564M
| $1.37M | ﹤0.01% |
34,327
+16,679
| +95% | +$639K |
|
4008
PUT
KRONOS Worldwide
KRO
$963M
| $1.37M | ﹤0.01% |
53,200
+43,900
| +472% | +$1.15M |
|
|
SGEN
4009
CALL
DELISTED
Seagen Inc. Common Stock
SGEN
| $1.37M | ﹤0.01% |
25,600
+1,300
| +5% | +$75.9K |
|
4010
Invesco Dorsey Wright SmallCap Momentum ETF
DWAS
$445M
| $1.37M | ﹤0.01% |
+28,176
| New | +$1.35M |
|
4011
CALL
Leidos
LDOS
$17.7B
| $1.37M | ﹤0.01% |
21,200
+8,200
| +63% | +$514K |
|
4012
PUT
ScottsMiracle-Gro
SMG
$3.61B
| $1.37M | ﹤0.01% |
12,800
+8,000
| +167% | +$799K |
|
4013
Suburban Propane Partners
SPH
$1.17B
| $1.37M | ﹤0.01% |
+56,512
| New | +$1.41M |
|
4014
UMB Financial
UMBF
$11.2B
| $1.37M | ﹤0.01% |
+19,032
| New | +$1.4M |
|
4015
PUT
Vornado Realty Trust
VNO
$7.24B
| $1.37M | ﹤0.01% |
17,500
-3,900
| -18% | -$298K |
|
|
ARRY
4016
CALL
DELISTED
Array Biopharma Inc
ARRY
| $1.37M | ﹤0.01% |
106,900
-6,400
| -6% | -$72.8K |
|
|
TCO
4017
CALL
DELISTED
Taubman Centers Inc.
TCO
| $1.37M | ﹤0.01% |
20,900
+13,400
| +179% | +$736K |
|
|
LNCE
4018
PUT
DELISTED
Snyders-Lance, Inc.
LNCE
| $1.37M | ﹤0.01% |
27,300
+22,000
| +415% | +$873K |
|
|
ARRY
4019
PUT
DELISTED
Array Biopharma Inc
ARRY
| $1.37M | ﹤0.01% |
106,700
-25,200
| -19% | -$287K |
|
4020
Atlantic Union Bankshares
AUB
$6.02B
| $1.36M | ﹤0.01% |
37,737
-41,691
| -52% | -$1.49M |
|
4021
CALL
IAMGOLD
IAG
$10.4B
| $1.36M | ﹤0.01% |
234,100
+31,000
| +15% | +$177K |
|
4022
PUT
Terex
TEX
$7.74B
| $1.36M | ﹤0.01% |
28,300
+2,300
| +9% | +$106K |
|
4023
CALL
CBRE Group
CBRE
$42.7B
| $1.36M | ﹤0.01% |
31,500
+11,700
| +59% | +$485K |
|
|
BIVV
4024
CALL
DELISTED
Bioverativ Inc. Common Stock
BIVV
| $1.36M | ﹤0.01% |
25,300
+9,300
| +58% | +$509K |
|
|
FIT
4025
CALL
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $1.36M | ﹤0.01% |
238,700
-268,900
| -53% | -$1.71M |
|
Similar funds
Citadel Advisors's Q4 2017 Portfolio in Review
As of Q4 2017, Citadel Advisors held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Citadel Advisors deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.
By sector, the portfolio is most concentrated in Technology at 6.1% of assets, down from 7% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.
- Citadel Advisors's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
- Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
- Citadel Advisors's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
- Citadel Advisors fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
- Citadel Advisors's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
- Citadel Advisors opened 1,440 new positions and closed 988 in Q4 2017.
- Citadel Advisors's portfolio value rose 26% quarter-over-quarter to $164B.
Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.